PLX

Thursday 4/14 Insider Buying Report: PLX, HCP

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Monday, Protalix BioTherapeutics' CEO, Dror Bashan, made a $102,000 purchase of PLX, buying 68,000 shares at a cost of $1.50 each. Bargain hunters can buy PLX at a price even lower than Bashan did, with shares trading as low as $1.33 at last check today which is 11.3% below Bashan's purchase price. Protalix BioTherapeutics is trading up about 0.8% on the day Thursday.

And at Hashicorp, there was insider buying on Monday, by Director Glenn Solomon who purchased 1,825 shares at a cost of $49.78 each, for a trade totaling $90,848. Hashicorp is trading down about 2.9% on the day Thursday. Solomon was up about 16.8% on the buy at the high point of today's trading session, with HCP trading as high as $58.12 in trading on Thursday.

VIDEO: Thursday 4/14 Insider Buying Report: PLX, HCP

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.